[HTML][HTML] The Modulatory Effects and Therapeutic Potential of Cannabidiol in the Gut
K Brown, K Funk, A Figueroa Barrientos, A Bailey… - Cells, 2024 - mdpi.com
Cannabidiol (CBD) is a major non-psychotropic phytocannabinoid that exists in the
Cannabis sativa plant. CBD has been found to act on various receptors, including both …
Cannabis sativa plant. CBD has been found to act on various receptors, including both …
Non-psychoactive cannabidiol prevents osteoporosis in an animal model and increases cell viability, proliferation, and osteogenic gene expression in human skeletal …
R Ihejirika-Lomedico, K Patel, DB Buchalter… - Calcified Tissue …, 2023 - Springer
Abstract Cannabidiol (CBD), the non-psychoactive component of the Cannabis sativa plant,
is marketed as a potential therapeutic agent and has been studied for its roles in reducing …
is marketed as a potential therapeutic agent and has been studied for its roles in reducing …
Cannabidiol decreases intestinal inflammation in the ovariectomized murine model of postmenopause
KMA Bacalia, KM Tveter, H Palmer, J Douyere… - Biomedicines, 2022 - mdpi.com
Cannabidiol (CBD)(25 mg/kg peroral) treatment was shown to improve metabolic outcomes
in ovariectomized (OVX) mice deficient in 17β-estradiol (E2). Herein, CBD effects on …
in ovariectomized (OVX) mice deficient in 17β-estradiol (E2). Herein, CBD effects on …
Historical perspective on the therapeutic potential of cannabidiol
FS Guimarães - International review of neurobiology, 2024 - pubmed.ncbi.nlm.nih.gov
Cannabidiol (CBD) is one of over 200 cannabinoids present in the Cannabis plant. Unlike
the plant's primary cannabinoid, delta-9-tetrahydrocannabinol (THC), CBD does not produce …
the plant's primary cannabinoid, delta-9-tetrahydrocannabinol (THC), CBD does not produce …